None listed
Conditions
Brief summary
The Vitamin D study in ACT Residential Care Facilities (RCFs)will examine whether a maintenance dose of vitamin D3 is effective in improving outcomes such as illness presentations, exacerbations of chronic illness, fractures and death in residents of aged care facilities. The main features of this trial are the assessment of 25(OH)D insufficiency and the commencement of the study drug or a placebo while a control group continues on the usual medications prescribed by thier GPs. After treatment with vitamin D3 or placebo for 12 months, the frequency of unplanned GP visits, hospitalisation, falls and mortality will be assessed.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Permenant residents of long-term care facilities in the ACT. Aged 65 years or more. Willing to partipate in the study.
Exclusion criteria
Residents with Aged Care Assesment Team ACFI assessment of 'High' for behaviour (verbal or physical).